(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved ... IQVIA data obtained by Glenmark is only available for all approved RLD indications. Glenmark's product is only approved for the ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund ...

1 Glenmark’s Clindamycin Phosphate Foam, 1% is only approved for the indication(s ... Note: IQVIA data obtained by Glenmark is only available for all approved RLD indications. Glenmark’s product is ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® ...

Keep this leaflet with your medicine. You may need to read it again. Clindamycin is an antibiotic. It is used to treat infections in different parts of the body caused by bacteria. Clindamycin ...